$IPXL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Impax Laboratories, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Impax Laboratories, LLC. Get notifications about new insider transactions in Impax Laboratories, LLC for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2011 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
May 13 2011 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Grant | A | 0.00 | 4,000 | 0 | 30,640 | 26.6 K to 30.6 K (+15.02 %) |
May 13 2011 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
May 13 2011 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Grant | A | 0.00 | 4,000 | 0 | 16,000 | 12 K to 16 K (+33.33 %) |
May 13 2011 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | A | 27.97 | 19,000 | 531,430 | 19,000 | |
May 13 2011 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
May 13 2011 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Grant | A | 0.00 | 4,000 | 0 | 43,095 | 39.1 K to 43.1 K (+10.23 %) |
May 13 2011 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
May 13 2011 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Grant | A | 0.00 | 4,000 | 0 | 53,625 | 49.6 K to 53.6 K (+8.06 %) |
May 13 2011 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Option Exercise | A | 27.97 | 115,000 | 3,216,550 | 115,000 | |
May 13 2011 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Grant | A | 0.00 | 46,000 | 0 | 436,793 | 390.8 K to 436.8 K (+11.77 %) |
Mar 04 2011 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Option Exercise | M | 6.50 | 10,000 | 65,000 | 0 | |
Mar 04 2011 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Payment of Exercise | F | 21.90 | 2,968 | 64,999 | 21,567 | 24.5 K to 21.6 K (-12.10 %) |
Mar 04 2011 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Buy | M | 6.50 | 10,000 | 65,000 | 24,535 | 14.5 K to 24.5 K (+68.80 %) |
Feb 16 2011 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Payment of Exercise | F | 23.89 | 968 | 23,126 | 40,576 | 41.5 K to 40.6 K (-2.33 %) |
Feb 03 2011 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Payment of Exercise | F | 18.97 | 550 | 10,434 | 41,544 | 42.1 K to 41.5 K (-1.31 %) |
Feb 03 2011 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Grant | A | 0.00 | 19,435 | 0 | 42,094 | 22.7 K to 42.1 K (+85.77 %) |
Feb 03 2011 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Payment of Exercise | F | 21.48 | 823 | 17,678 | 22,659 | 23.5 K to 22.7 K (-3.50 %) |
Feb 03 2011 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Payment of Exercise | F | 21.45 | 906 | 19,434 | 23,482 | 24.4 K to 23.5 K (-3.71 %) |
Dec 13 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Option Exercise | M | 6.55 | 1,000 | 6,550 | 44,000 | |
Dec 13 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Option Exercise | M | 8.00 | 7,500 | 60,000 | 0 | |
Dec 13 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Sell | S | 18.70 | 8,500 | 158,950 | 26,640 | 35.1 K to 26.6 K (-24.19 %) |
Dec 13 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Buy | M | 6.55 | 1,000 | 6,550 | 35,140 | 34.1 K to 35.1 K (+2.93 %) |
Dec 13 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Buy | M | 8.00 | 7,500 | 60,000 | 34,140 | 26.6 K to 34.1 K (+28.15 %) |
Dec 13 2010 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Gift | G | 0.00 | 4,000 | 0 | 3,000 | 7 K to 3 K (-57.14 %) |
Dec 06 2010 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Option Exercise | M | 7.10 | 7,500 | 53,250 | 0 | |
Dec 06 2010 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Option Exercise | M | 10.19 | 2,000 | 20,380 | 0 | |
Dec 06 2010 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Payment of Exercise | F | 18.29 | 2,911 | 53,242 | 49,625 | 52.5 K to 49.6 K (-5.54 %) |
Dec 06 2010 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Payment of Exercise | F | 18.29 | 1,114 | 20,375 | 52,536 | 53.7 K to 52.5 K (-2.08 %) |
Dec 06 2010 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Buy | M | 7.10 | 7,500 | 53,250 | 53,650 | 46.2 K to 53.7 K (+16.25 %) |
Dec 06 2010 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Buy | M | 10.19 | 2,000 | 20,380 | 46,150 | 44.2 K to 46.2 K (+4.53 %) |
Dec 03 2010 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 6.55 | 10,000 | 65,500 | 65,000 | |
Dec 03 2010 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 8.00 | 4,000 | 32,000 | 3,500 | |
Dec 03 2010 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Sell | S | 18.10 | 10,000 | 181,000 | 7,000 | 17 K to 7 K (-58.82 %) |
Dec 03 2010 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 6.55 | 10,000 | 65,500 | 17,000 | 7 K to 17 K (+142.86 %) |
Dec 03 2010 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 8.00 | 4,000 | 32,000 | 7,000 | 3 K to 7 K (+133.33 %) |
Nov 09 2010 | IPXL | IMPAX LABORATORIES ... | Mengler Christopher | Sell | S | 19.32 | 7,460 | 144,127 | 0 | 7.5 K to 0 (-100.00 %) | |
Nov 03 2010 | IPXL | IMPAX LABORATORIES ... | Mengler Christopher | Sell | S | 21.24 | 40,956 | 869,905 | 7,460 | 48.4 K to 7.5 K (-84.59 %) | |
Nov 03 2010 | IPXL | IMPAX LABORATORIES ... | Mengler Christopher | Sell | S | 21.26 | 2,000 | 42,520 | 29,666 | 31.7 K to 29.7 K (-6.32 %) | |
Aug 20 2010 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Buy | P | 15.72 | 13,800 | 216,936 | 180,000 | 166.2 K to 180 K (+8.30 %) |
Aug 17 2010 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Buy | P | 16.03 | 20,000 | 320,600 | 20,000 | 0 to 20 K |
Aug 17 2010 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Buy | P | 16.03 | 20,000 | 320,600 | 116,000 | 96 K to 116 K (+20.83 %) |
Aug 17 2010 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Buy | P | 16.03 | 6,200 | 99,386 | 166,200 | 160 K to 166.2 K (+3.88 %) |
Aug 17 2010 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Buy | P | 16.06 | 1,645 | 26,419 | 3,645 | 2 K to 3.6 K (+82.25 %) |
Aug 12 2010 | IPXL | IMPAX LABORATORIES ... | Mengler Christopher | President, Global P ... | Buy | P | 15.19 | 2,000 | 30,380 | 59,706 | 57.7 K to 59.7 K (+3.47 %) |
Aug 12 2010 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Buy | P | 15.40 | 5,000 | 77,000 | 2,369,568 | 2.4 M to 2.4 M (+0.21 %) |
Aug 12 2010 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Buy | P | 16.03 | 10,000 | 160,300 | 2,364,568 | 2.4 M to 2.4 M (+0.42 %) |
Aug 12 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Option Exercise | M | 7.10 | 7,500 | 53,250 | 0 | |
Aug 12 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Sell | S | 16.83 | 7,500 | 126,225 | 26,640 | 34.1 K to 26.6 K (-21.97 %) |
Aug 12 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Buy | M | 7.10 | 7,500 | 53,250 | 34,140 | 26.6 K to 34.1 K (+28.15 %) |
Aug 05 2010 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Option Exercise | M | 5.00 | 50,000 | 250,000 | 0 | |
Aug 05 2010 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Buy | M | 5.00 | 50,000 | 250,000 | 390,793 | 340.8 K to 390.8 K (+14.67 %) |
Jun 08 2010 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Payment of Exercise | F | 20.37 | 2,751 | 56,038 | 51,950 | 54.7 K to 52 K (-5.03 %) |
Jun 08 2010 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Sell | S | 20.51 | 1,465 | 30,047 | 14,535 | 16 K to 14.5 K (-9.16 %) |
Jun 08 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Sell | S | 20.37 | 1,360 | 27,703 | 26,640 | 28 K to 26.6 K (-4.86 %) |
Jun 08 2010 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Sell | S | 20.32 | 1,000 | 20,320 | 44,150 | 45.2 K to 44.2 K (-2.21 %) |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Option Exercise | A | 20.30 | 10,000 | 203,000 | 10,000 | |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Grant | A | 0.00 | 4,000 | 0 | 16,000 | 12 K to 16 K (+33.33 %) |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Option Exercise | A | 20.30 | 32,500 | 659,750 | 32,500 | |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Grant | A | 0.00 | 13,000 | 0 | 54,701 | 41.7 K to 54.7 K (+31.17 %) |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | Mengler Christopher | President, Global P ... | Option Exercise | A | 20.30 | 32,500 | 659,750 | 32,500 | |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | Mengler Christopher | President, Global P ... | Grant | A | 0.00 | 13,000 | 0 | 57,706 | 44.7 K to 57.7 K (+29.08 %) |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Option Exercise | A | 20.30 | 10,000 | 203,000 | 10,000 | |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Grant | A | 0.00 | 4,000 | 0 | 12,000 | 8 K to 12 K (+50.00 %) |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | KOCH ARTHUR A JR | SVP, Finance, and C ... | Option Exercise | A | 20.30 | 32,500 | 659,750 | 32,500 | |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | KOCH ARTHUR A JR | SVP, Finance, and C ... | Grant | A | 0.00 | 13,000 | 0 | 102,966 | 90 K to 103 K (+14.45 %) |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Option Exercise | A | 20.30 | 115,000 | 2,334,500 | 115,000 | |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Grant | A | 0.00 | 46,000 | 0 | 340,793 | 294.8 K to 340.8 K (+15.60 %) |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | Hildenbrand Charles V | SVP, Operations | Option Exercise | A | 20.30 | 22,500 | 456,750 | 22,500 | |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | Hildenbrand Charles V | SVP, Operations | Grant | A | 0.00 | 9,000 | 0 | 38,524 | 29.5 K to 38.5 K (+30.48 %) |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Option Exercise | A | 20.30 | 10,000 | 203,000 | 10,000 | |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Grant | A | 0.00 | 4,000 | 0 | 28,000 | 24 K to 28 K (+16.67 %) |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Option Exercise | A | 20.30 | 12,000 | 243,600 | 12,000 | |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Grant | A | 0.00 | 4,800 | 0 | 39,095 | 34.3 K to 39.1 K (+14.00 %) |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Option Exercise | A | 20.30 | 10,000 | 203,000 | 10,000 | |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Grant | A | 0.00 | 4,000 | 0 | 45,150 | 41.2 K to 45.2 K (+9.72 %) |
May 28 2010 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | A | 20.30 | 19,000 | 385,700 | 19,000 | |
May 24 2010 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Option Exercise | M | 6.55 | 15,000 | 98,250 | 30,000 | |
May 24 2010 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Sell | S | 19.80 | 4,000 | 79,200 | 8,000 | 12 K to 8 K (-33.33 %) |
May 24 2010 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Sell | S | 19.87 | 15,000 | 298,050 | 12,000 | 27 K to 12 K (-55.56 %) |
May 24 2010 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Buy | M | 6.55 | 15,000 | 98,250 | 27,000 | 12 K to 27 K (+125.00 %) |
May 24 2010 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Payment of Exercise | F | 19.65 | 1,193 | 23,442 | 41,701 | 42.9 K to 41.7 K (-2.78 %) |
May 24 2010 | IPXL | IMPAX LABORATORIES ... | KOCH ARTHUR A JR | SVP, Finance, and C ... | Payment of Exercise | F | 19.65 | 9,034 | 177,518 | 89,966 | 99 K to 90 K (-9.13 %) |
May 24 2010 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Payment of Exercise | F | 19.65 | 14,234 | 279,698 | 294,793 | 309 K to 294.8 K (-4.61 %) |
May 24 2010 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Payment of Exercise | F | 13.91 | 1,012 | 14,077 | 24,388 | 25.4 K to 24.4 K (-3.98 %) |
May 24 2010 | IPXL | IMPAX LABORATORIES ... | Hildenbrand Charles V | SVP, Operations | Payment of Exercise | F | 19.65 | 2,476 | 48,653 | 29,524 | 32 K to 29.5 K (-7.74 %) |
May 19 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Option Exercise | M | 5.63 | 8,000 | 45,000 | 0 | |
May 19 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Sell | S | 19.50 | 8,000 | 156,000 | 24,000 | 32 K to 24 K (-25.00 %) |
May 19 2010 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Buy | M | 5.63 | 8,000 | 45,000 | 32,000 | 24 K to 32 K (+33.33 %) |
May 10 2010 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 10.19 | 12,000 | 122,280 | 0 | |
May 10 2010 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Sell | S | 17.10 | 12,000 | 205,189 | 3,000 | 15 K to 3 K (-80.00 %) |
May 10 2010 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 10.19 | 12,000 | 122,280 | 15,000 | 3 K to 15 K (+400.00 %) |
Mar 09 2010 | IPXL | IMPAX LABORATORIES ... | Mengler Christopher | President, Global P ... | Payment of Exercise | F | 16.48 | 2,294 | 37,805 | 44,706 | 47 K to 44.7 K (-4.88 %) |
Mar 04 2010 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Option Exercise | M | 8.00 | 7,500 | 60,000 | 0 | |
Mar 04 2010 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Option Exercise | M | 7.10 | 7,500 | 53,250 | 0 | |
Mar 04 2010 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Sell | S | 15.38 | 15,000 | 230,700 | 12,000 | 27 K to 12 K (-55.56 %) |
Mar 04 2010 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Buy | M | 8.10 | 7,500 | 60,750 | 27,000 | 19.5 K to 27 K (+38.46 %) |
Mar 04 2010 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Buy | M | 7.10 | 7,500 | 53,250 | 19,500 | 12 K to 19.5 K (+62.50 %) |
Dec 30 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Option Exercise | A | 9.27 | 23,000 | 213,210 | 23,000 | |
Dec 30 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Option Exercise | A | 5.06 | 23,000 | 116,380 | 23,000 | |
Dec 30 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Gift | G | 0.00 | 2,235 | 0 | 309,027 | 306.8 K to 309 K (+0.73 %) |
Dec 30 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Gift | G | 0.00 | 2,235 | 0 | 25,400 | 27.6 K to 25.4 K (-8.09 %) |
Dec 30 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Payment of Exercise | F | 11.34 | 550 | 6,237 | 27,635 | 28.2 K to 27.6 K (-1.95 %) |
Dec 30 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Grant | A | 0.00 | 9,200 | 0 | 28,185 | 19 K to 28.2 K (+48.46 %) |
Dec 30 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Payment of Exercise | F | 9.23 | 715 | 6,599 | 18,985 | 19.7 K to 19 K (-3.63 %) |
Dec 30 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Gift | G | 0.00 | 1,000 | 0 | 2,354,568 | 2.4 M to 2.4 M (-0.04 %) |
Dec 30 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Gift | G | 0.00 | 9,000 | 0 | 2,355,568 | 2.4 M to 2.4 M (-0.38 %) |
Dec 30 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Gift | G | 0.00 | 6,000 | 0 | 2,364,568 | 2.4 M to 2.4 M (-0.25 %) |
Dec 30 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Gift | G | 0.00 | 2,249 | 0 | 306,792 | 304.5 K to 306.8 K (+0.74 %) |
Dec 30 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Gift | G | 0.00 | 2,249 | 0 | 19,700 | 21.9 K to 19.7 K (-10.25 %) |
Nov 12 2009 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Payment of Exercise | F | 7.55 | 2,681 | 20,242 | 42,894 | 45.6 K to 42.9 K (-5.88 %) |
Nov 12 2009 | IPXL | IMPAX LABORATORIES ... | OH KIM SUN | Director | Option Exercise | M | 4.00 | 2,000 | 8,000 | 0 | |
Nov 12 2009 | IPXL | IMPAX LABORATORIES ... | OH KIM SUN | Director | Buy | M | 4.00 | 2,000 | 8,000 | 14,000 | 12 K to 14 K (+16.67 %) |
Nov 09 2009 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Option Exercise | M | 5.63 | 2,000 | 11,250 | 0 | |
Nov 09 2009 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Option Exercise | M | 4.00 | 2,000 | 8,000 | 0 | |
Nov 09 2009 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Sell | S | 9.70 | 4,000 | 38,800 | 12,000 | 16 K to 12 K (-25.00 %) |
Nov 09 2009 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Buy | M | 5.63 | 2,000 | 11,250 | 16,000 | 14 K to 16 K (+14.29 %) |
Nov 09 2009 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Buy | M | 4.00 | 2,000 | 8,000 | 14,000 | 12 K to 14 K (+16.67 %) |
Aug 18 2009 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Option Exercise | M | 4.00 | 4,000 | 16,000 | 0 | |
Aug 18 2009 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Sell | S | 7.69 | 4,000 | 30,770 | 24,000 | 28 K to 24 K (-14.29 %) |
Aug 18 2009 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Buy | M | 4.00 | 4,000 | 16,000 | 28,000 | 24 K to 28 K (+16.67 %) |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | OH KIM SUN | Director | Option Exercise | A | 6.55 | 45,000 | 294,750 | 45,000 | |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | OH KIM SUN | Director | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Option Exercise | A | 6.55 | 45,000 | 294,750 | 45,000 | |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | A | 6.55 | 75,000 | 491,250 | 75,000 | |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Option Exercise | A | 6.55 | 45,000 | 294,750 | 45,000 | |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Grant | A | 0.00 | 12,000 | 0 | 24,000 | 12 K to 24 K (+100.00 %) |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | Hildenbrand Charles V | SVP, Operations | Option Exercise | A | 6.55 | 117,500 | 769,625 | 117,500 | |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | Hildenbrand Charles V | SVP, Operations | Grant | A | 0.00 | 27,000 | 0 | 32,000 | 5 K to 32 K (+540.00 %) |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Option Exercise | A | 6.55 | 32,500 | 212,875 | 32,500 | |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Grant | A | 0.00 | 13,000 | 0 | 45,575 | 32.6 K to 45.6 K (+39.91 %) |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Option Exercise | A | 6.55 | 45,000 | 294,750 | 45,000 | |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Option Exercise | A | 6.55 | 495,000 | 3,242,250 | 495,000 | |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Grant | A | 0.00 | 138,000 | 0 | 304,543 | 166.5 K to 304.5 K (+82.86 %) |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | KOCH ARTHUR A JR | SVP, Finance, and C ... | Option Exercise | A | 6.55 | 122,500 | 802,375 | 122,500 | |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | KOCH ARTHUR A JR | SVP, Finance, and C ... | Grant | A | 0.00 | 89,000 | 0 | 99,000 | 10 K to 99 K (+890.00 %) |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Option Exercise | A | 6.55 | 45,000 | 294,750 | 45,000 | |
May 22 2009 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Grant | A | 0.00 | 12,000 | 0 | 41,150 | 29.2 K to 41.2 K (+41.17 %) |
May 12 2009 | IPXL | IMPAX LABORATORIES ... | Mengler Christopher | President, Global P ... | Buy | P | 5.85 | 1,000 | 5,850 | 47,000 | 46 K to 47 K (+2.17 %) |
Apr 14 2009 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | President and CEO | Grant | A | 0.00 | 9,200 | 0 | 21,949 | 12.7 K to 21.9 K (+72.16 %) |
Mar 25 2009 | IPXL | IMPAX LABORATORIES ... | Mengler Christopher | President, Global P ... | Buy | P | 5.50 | 1,000 | 5,500 | 46,000 | 45 K to 46 K (+2.22 %) |
Mar 17 2009 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Buy | P | 5.59 | 2,000 | 11,180 | 2,000 | 0 to 2 K |
Mar 16 2009 | IPXL | IMPAX LABORATORIES ... | Hildenbrand Charles V | SVP, Operations | Buy | P | 5.75 | 5,000 | 28,750 | 5,000 | 0 to 5 K |
Mar 13 2009 | IPXL | IMPAX LABORATORIES ... | Mengler Christopher | President, Global P ... | Option Exercise | A | 6.00 | 75,000 | 450,000 | 75,000 | |
Mar 13 2009 | IPXL | IMPAX LABORATORIES ... | Mengler Christopher | President, Global P ... | Buy | P | 5.50 | 5,000 | 27,500 | 45,000 | 40 K to 45 K (+12.50 %) |
Mar 13 2009 | IPXL | IMPAX LABORATORIES ... | Mengler Christopher | President, Global P ... | Grant | A | 0.00 | 30,000 | 0 | 40,000 | 10 K to 40 K (+300.00 %) |
Mar 04 2009 | IPXL | IMPAX LABORATORIES ... | Mengler Christopher | President, Global P ... | Buy | P | 6.00 | 10,000 | 60,000 | 10,000 | 0 to 10 K |
Jan 27 2009 | IPXL | IMPAX LABORATORIES ... | KOCH ARTHUR A JR | SVP, Finance, and C ... | Buy | P | 5.00 | 5,000 | 25,000 | 10,000 | 5 K to 10 K (+100.00 %) |